| Primary |
| Product Used For Unknown Indication |
60.5% |
| Lower Respiratory Tract Infection |
9.7% |
| Urinary Tract Infection |
8.1% |
| Atrial Fibrillation |
4.0% |
| Anaemia |
1.6% |
| Antibiotic Prophylaxis |
1.6% |
| Axillary Mass |
1.6% |
| Nephrotic Syndrome |
1.6% |
| Pneumonia Escherichia |
1.6% |
| Upper Respiratory Tract Infection |
1.6% |
| Bronchitis |
0.8% |
| Cellulitis |
0.8% |
| Erythema |
0.8% |
| Infection |
0.8% |
| Infection Prophylaxis |
0.8% |
| Infective Exacerbation Of Chronic Obstructive Airways Disease |
0.8% |
| Oedema Peripheral |
0.8% |
| Osteomyelitis |
0.8% |
| Pre-eclampsia |
0.8% |
| Prophylaxis |
0.8% |
|
| Treatment Failure |
25.0% |
| Acute Generalised Exanthematous Pustulosis |
7.5% |
| International Normalised Ratio Increased |
7.5% |
| Urticaria |
7.5% |
| Liver Function Test Abnormal |
5.0% |
| Rash |
5.0% |
| Syncope |
5.0% |
| Urinary Tract Infection |
5.0% |
| Wound Decomposition |
5.0% |
| Clostridium Difficile Infection |
2.5% |
| Coeliac Disease |
2.5% |
| Diarrhoea |
2.5% |
| Drug Hypersensitivity |
2.5% |
| Hypersensitivity |
2.5% |
| Jaundice Cholestatic |
2.5% |
| Lichenoid Keratosis |
2.5% |
| Mouth Ulceration |
2.5% |
| Neonatal Respiratory Distress Syndrome |
2.5% |
| Nervous System Disorder |
2.5% |
| Pain |
2.5% |
|
| Secondary |
| Product Used For Unknown Indication |
76.9% |
| Hypertension |
4.6% |
| Cellulitis |
2.5% |
| Impetigo |
1.4% |
| Muscle Spasms |
1.4% |
| Lower Respiratory Tract Infection |
1.1% |
| Malaise |
1.1% |
| Nasopharyngitis |
1.1% |
| Oral Herpes |
1.1% |
| Prophylaxis |
1.1% |
| Sinus Disorder |
1.1% |
| Smoking Cessation Therapy |
1.1% |
| Antibiotic Prophylaxis |
0.7% |
| Bronchitis |
0.7% |
| Glioblastoma Multiforme |
0.7% |
| Hypersensitivity |
0.7% |
| Infection |
0.7% |
| Joint Injury |
0.7% |
| Multiple Allergies |
0.7% |
| Prostatitis |
0.7% |
|
| Clostridium Difficile Infection |
14.3% |
| Pancreatitis |
11.4% |
| Premature Baby |
8.6% |
| Tinnitus |
8.6% |
| Serratia Infection |
5.7% |
| Treatment Failure |
5.7% |
| Urinary Tract Infection |
5.7% |
| Vestibular Disorder |
5.7% |
| Angioedema |
2.9% |
| Face Oedema |
2.9% |
| Gastrointestinal Haemorrhage |
2.9% |
| Hepatitis |
2.9% |
| Nausea |
2.9% |
| Off Label Use |
2.9% |
| Rash |
2.9% |
| Rash Papular |
2.9% |
| Renal Failure |
2.9% |
| Respiratory Disorder |
2.9% |
| Sepsis |
2.9% |
| Serratia Test Positive |
2.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
35.4% |
| Drug Use For Unknown Indication |
11.0% |
| Hypertension |
6.6% |
| Urinary Tract Infection |
6.2% |
| Drug Exposure During Pregnancy |
5.1% |
| Prophylaxis |
4.2% |
| Asthma |
3.5% |
| Pain |
3.5% |
| Rheumatoid Arthritis |
3.3% |
| Mastitis |
2.6% |
| Infection |
2.4% |
| Prophylaxis Against Transplant Rejection |
2.4% |
| Anaemia |
2.0% |
| Constipation |
2.0% |
| Depression |
2.0% |
| Dementia Alzheimer's Type |
1.8% |
| Sinusitis |
1.8% |
| Bronchitis |
1.5% |
| Osteoporosis |
1.5% |
| Prostate Cancer |
1.3% |
|
| Sexual Dysfunction |
12.5% |
| Renal Failure Chronic |
7.8% |
| Urinary Retention |
7.8% |
| Drug Ineffective |
6.3% |
| Talipes |
6.3% |
| Vomiting |
6.3% |
| Clostridium Difficile Infection |
4.7% |
| Pneumonia |
4.7% |
| Rash |
4.7% |
| Throat Tightness |
4.7% |
| Toxic Encephalopathy |
4.7% |
| Unevaluable Event |
4.7% |
| Cardiac Disorder |
3.1% |
| Deafness Neurosensory |
3.1% |
| Head Deformity |
3.1% |
| Lower Respiratory Tract Infection |
3.1% |
| Malaise |
3.1% |
| Miller Fisher Syndrome |
3.1% |
| Morbid Thoughts |
3.1% |
| Pain In Extremity |
3.1% |
|
